The Ever Changing Screens For Breast Cancer

We are seeing a lot of NFL players wearing pink this month. Every October, we celebrate our progress against breast cancer and push to make people aware of the disease and help hunt for a cure. Of course, when efforts such as these have come before, we were strong, and the winners against cancer. All one must do is look back at 1960 and see a horrible disease that has leukemia, and now, 95% survival and 60% remission rates were the rule. Or how about cervical cancer and cancers, and our success against the one time the leading cause of cancer death in women, is now under control.

National Breast Cancer Awareness Month is so important. Over the years has helped raise awareness about the severity of the disease in the medical and economic impact. Ultimately, we are looking for ways to save human lives. A lot has changed over the years. One thing to remember is that just not so long ago, we "Baby Boomers" looked like our mother died of cancer the most common causes of death in women, cancer of the uterus. This is true. Until the early 1970s, it is the most common cancer in the killing of women. Coping with breast cancer is underway, with the diagnostic screening of meeting the new challenges around every corner.

In 1959, the introduction of standard screen called the Papanicolaou (Pap) test changes everything, and a national campaign to get women to the doctor Pap screening has created the paradigm in the routine care of women during a visit to your doctor. With this tool, we eventually discovered that the culprit is now known as the "papilloma virus," we were able to develop a vaccine. With this victory, however, breast cancer has become a real villain in the removal of women. It has become very extensive, including all kinds of theories as to cause, including all of the drugs, hormones and lifestyle practices oncogenetics and environmental exposure.

Controversial guidelines into physical projection and image continues to change. Economically, it seems sometimes that insurance companies are driven by our screening study. Based on the guidelines thready actuarial information, constantly changing mammography guidelines, jumping to any information that suggests spending less on review. Now, recent studies suggest that mammography may not be as important as what is meant to reduce women's risk of dying from breast cancer. Coming on the heels of changes in guidelines from the U.S. Preventive Services Task Force in 2009, suggesting women do not need mammograms in their 40s, this latest study, published in The New England Journal of Medicine, adds a "scratch head" position of the idea that mammography make a significant impact in saving lives.

study, conducted in Norway, showed that women who receive breast cancer screenings have a 10 percent lower risk of death from cancer, but scientists were able to follow only a third of the so-called reduced risk of mammography itself. Projections of reduced deaths from breast cancer by only 2.4 per 100,000 žena.Norveški study followed more than 40,000 women with breast cancer.

study, conducted in Norway, showed that women who receive breast cancer screenings have a 10 percent lower risk of death from cancer, but scientists were able to follow only a third of the so-called reduced risk of mammography itself. Projections of reduced deaths from breast cancer by only 2.4 per 100,000 žena.Norveški study followed more than 40,000 women with breast cancer.

study, conducted in Norway, showed that women who receive breast cancer screenings have a 10 percent lower risk of death from cancer, but scientists were able to follow only a third of the so-called reduced risk of mammography itself. Projections of reduced deaths from breast cancer by only 2.4 per 100,000 žena.Norveški study followed more than 40,000 women with breast cancer.

study, conducted in Norway, showed that women who receive breast cancer screenings have a 10 percent lower risk of death from cancer, but scientists were able to follow only a third of the so-called reduced risk of mammography itself. Projections of reduced deaths from breast cancer by only 2.4 per 100,000 žena.Norveški study followed more than 40,000 women with breast cancer.

American women should not be too quick to give up is recommended every two years projections for breast cancer for those over 50 years, however. Dr. Otis Brawley, chief medical officer of the American Cancer Society, feels the Norwegian study was too short in duration. According to Dr. Brawley, "The report is to assess the relative value of mammography is lower than the number of previous reviews of studies." This may be due to the relatively short two years of monitoring the population. Brawley said that the majority of randomized studies with at least 10 years of monitoring after the last round of projections, and many have covered a period of 20-40 years.

As a physician, I must add that the ability to perform a thorough medical palpatory examination is crucial. Many doctors only patient to lie on the examination table and circumferentially feel both breasts are examined and considered. A real doctor will ask relevant questions, and examining the "patient" and not just their breasts. In addition, the examination should begin with a visual examination of the patient and her breasts, looking carefully for the skin and nipple changes, and then use maneuvers that force breast tissue to respond to different angles of muscle contractions along the chest wall. It comprises the lesions deep along ligamentous attachments to the chest. It should then follow with a very thorough palpatory examination of both breasts and armpits.

Dr. Counce